Loading clinical trials...

Concordance AUTOFEVG | Clinical Trials | Clareo Health

COMPLETEDNA

Concordance AUTOFEVG

Evaluation of the Ejection Fraction of the Left Ventricle Ejection Fraction (LVEF) by a New Automatic Evaluation Tool in a Pocket Ultrasound Device: Study of Concordance With the Estimated by Cardiac Magnetic Reasoning Imaging (MRI)

NCT04641169•Centre Hospitalier Universitaire de Nīmes

View on ClinicalTrials.gov

Summary

Clinical ultrasound has become essential in emergency medicine. The guidelines are to use of echocardiography in specific contexts: dyspnea, hypotension or chest pain. The evaluation of left ventricle ejection fraction (LVEF) is one of the basic objectives of echocardiography. The reference assessment in emergency medicine is visual assessment. It suffers from poor inter-observer reproducibility. Pocket ultrasound scanners seem to meet the constraints of point-of-care ultrasound. A new tool is available on a pocket ultrasound device: the automatic evaluation of LVEF. Its interest could be to have a better inter-observer reproducibility than visual evaluation.

Eligibility

Age

18 - No limit years

Sex

ALL

Healthy Volunteers

Inclusion Criteria

•Patient over 18 years of age
•Management in the investigator centre
•Admitted for dyspnea or hypotension or chest pain

Exclusion Criteria

•Age \< 18 years
•Patient not benefiting from a social security system
•Patient deprived of liberty
•Patient under the protection of justice, under guardianship or curatorship
•Patient refusing to participate in the study
•Inability to provide the patient with informed information

Locations (1)

CHRU de Nîmes - Hôpital Universitaire Carémeau

Nîmes, France

Key Dates

Start Date

June 8, 2021

Primary Completion Date

July 8, 2022

Completion Date

July 8, 2022

Last Updated

December 4, 2025

Enrollment

ACTUAL participants

Conditions

EchocardiographyMedicine, EmergencyTechnology Assessment, BiomedicalHeart Diseases

Interventions

echocardiography

PROCEDURE

Prediction of Fluid Responsiveness in Paediatric Patients With Septic Shock Using Carotid Doppler Ultrasonography and Echocardiography

NCT07136532

Septic ShockEchocardiography Guided Fluid Management

View study

RECRUITING

Impact of Echocardiography on Management of Critically Ill Neonates

NCT06533787

Critical IllnessEchocardiography+1 more

View study

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: December 4, 2025Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

Concordance AUTOFEVG

Inclusion Criteria

Exclusion Criteria

Prediction of Fluid Responsiveness in Paediatric Patients With Septic Shock Using Carotid Doppler Ultrasonography and Echocardiography

Impact of Echocardiography on Management of Critically Ill Neonates

The Echodynamic Approach

Multimodal Cardiac Imaging Registry in Patients with Atrial Fibrillation

Contrast Specific Echocardiogram Versus Left Ventricular Opacification (LVO) Imaging Settings

Insertion of a Transoesophageal Echocardiography Probe Using McGRATH